1. The Ashwell receptor mitigates the lethal coagulopathy of sepsis
- Author
-
Grewal, Prabhjit K., Uchiyama, Satoshi, Ditto, David, Varki, Nissi, Lea, Dzung T., Nizet, Victor, and Marth, Jamey D.
- Subjects
Lectins -- Physiological aspects ,Lectins -- Genetic aspects ,Lectins -- Research ,Sepsis -- Complications and side effects ,Sepsis -- Care and treatment ,Sepsis -- Patient outcomes ,Von Willebrand factor -- Health aspects ,Von Willebrand factor -- Research ,Glycoproteins -- Health aspects ,Glycoproteins -- Research ,Blood clot -- Risk factors ,Blood clot -- Drug therapy ,Blood clot -- Research ,Thrombosis -- Risk factors ,Thrombosis -- Drug therapy ,Thrombosis -- Research - Abstract
The Ashwell receptor, the major lectin of hepatocytes, rapidly clears from blood circulation glycoproteins bearing glycan ligands that include galactose and N-acetylgalactosamine. This asialoglycoprotein receptor activity remains a key factor in the development and administration of glycoprotein pharmaceuticals, yet a biological purpose of the Ashwell receptor has remained elusive. We have identified endogenous ligands of the Ashwell receptor as glycoproteins and regulatory components in blood coagulation and thrombosis that include von Willebrand factor (vWF) and platelets. The Ashwell receptor normally modulates vWF homeostasis and is responsible for thrombocytopenia during systemic Streptococcus pneumoniae infection by eliminating platelets desialylated by the bacterium's neuraminidase. Hemostatic adaptation by the Ashwell receptor moderates the onset and severity of disseminated intravascular coagulation during sepsis and improves the probability of host survival., The liver controls the removal of exogenously administered glycoproteins from circulation, as discovered over 35 years ago (1-4). These classical investigations identified the first vertebrate lectin as a hepatic receptor [...]
- Published
- 2008